Corium Reports Third Quarter Fiscal 2015 Financial Results
July 29, 2015 16:03 ET
|
Corium International, Inc.
MENLO PARK, Calif., July 29, 2015 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and...
Corium Announces Positive Topline Results From Phase 2a Study of Transdermal MicroCor(R) PTH in Post-Menopausal Women
July 28, 2015 16:05 ET
|
Corium International, Inc.
Demonstrates Rapid Drug Uptake, Significant Increases in Bone Formation Biomarkers and Excellent Skin Tolerability
Company to Webcast Third Quarter Fiscal 2015 Results and Discussion of Topline...
Corium Co-Founder Dr. Gary W. Cleary Honored With Controlled Release Society Founders Award
July 27, 2015 08:00 ET
|
Corium International, Inc.
MENLO PARK, Calif., July 27, 2015 (GLOBE NEWSWIRE) -- Corium International, Inc. (NASDAQ:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and...
Corium to Present at Jefferies 2015 Global Healthcare Conference
May 20, 2015 08:00 ET
|
Corium International, Inc.
MENLO PARK, Calif., May 20, 2015 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and...
Corium Announces Publication of Promising Data for Needle-Free Transdermal Influenza Vaccine
May 18, 2015 12:20 ET
|
Corium International, Inc.
MENLO PARK, Calif., May 18, 2015 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and...
Corium Reports Second Quarter Fiscal 2015 Financial Results
May 07, 2015 16:05 ET
|
Corium International, Inc.
MENLO PARK, Calif., May 7, 2015 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization...
Corium to Report Second Quarter Fiscal 2015 Financial Results on Thursday, May 7, 2015
April 30, 2015 08:00 ET
|
Corium International, Inc.
MENLO PARK, Calif., April 30, 2015 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq:CORI) today announced that it will report financial results for the Second Quarter Fiscal 2015 on Thursday,...
Aequus and Corium Enter Into Product Development Collaboration Focused on CNS
April 28, 2015 16:05 ET
|
Corium International, Inc.
MENLO PARK, Calif. and VANCOUVER, British Columbia, April 28, 2015 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc., (Aequus) (TSX-V:AQS), a specialty life sciences company focused on providing...
Joseph J. Sarret, M.D., J.D. Joins Corium as Chief Business Officer
April 28, 2015 08:00 ET
|
Corium International, Inc.
MENLO PARK, Calif., April 28, 2015 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and...
Corium to Present at the 14th Annual Needham Healthcare Conference
April 02, 2015 08:00 ET
|
Corium International, Inc.
MENLO PARK, Calif., April 2, 2015 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and...